
|Videos|July 5, 2022
Dr. Desai on selection criteria for the ideal candidate for bladder preservation surgery
Author(s)Urology Times staff
"A key overarching question is whether there is just a higher burden/stage of disease “beyond which we don’t think a bladder preservation is likely to provide durable disease control,” says Neil Desai, MD.
Advertisement
Neil Desai, MD, associate professor of Radiation Oncology at UT Southwestern Medical Center, discusses key factors when considering whether a patient with bladder cancer is eligible to receive bladder-sparing surgery.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves first-line Zenflow system for the treatment of BPH
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5


















